Novartis Chief Executive Daniel Vasella has been the industry's great philosopher on dealmaking, but he has yet to buy another branded drugmaker.
FORBES: If Novartis Steps In, Will Pfizer Follow?
应用推荐
模块上移
模块下移
不移动